Altria Group (MO) is back in focus after Q1 2026 revenue and earnings surpassed expectations, prompting upward earnings estimate revisions and fresh buy ratings, even as the stock lags the broader market.

Altria’s share price has eased over the past month, with a 30 day share price return of down 4.24%. However, momentum over a longer horizon remains positive given the 22.67% year to date share price return and very strong multi year total shareholder returns.

If strong income potential has you looking beyond a single tobacco stock, it could be worth scanning for high yield opportunities with resilient payouts in the 10 dividend fortresses

With Altria trading near its analyst price target yet at an estimated intrinsic discount, investors are left with a key question: is the stock still undervalued here, or has the market already priced in future growth?

Most Popular Narrative: 7.3% Overvalued

Altria’s narrative fair value of $65.50 sits below the last close at $70.30, which is why this widely followed view frames the stock as slightly rich.

Altria faces challenges in the e-vapor category due to the prevalence of illicit products, which constitute over 60% of the market. This limits their ability to generate revenue from legitimate e-vapor products, impacting future revenue growth.

The fair value story leans on steady top line assumptions, expanding margins and a future earnings multiple that undercuts today’s pricing. Curious how those three pieces fit together.

Result: Fair Value of $65.50 (OVERVALUED)

However, if traditional tobacco volumes stay resilient or oral products like on! gain more traction, current assumptions around margin pressure and flat growth could prove too cautious.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another Valuation Lens: Deep Discount on Cash Flows

While the narrative fair value of $65.50 suggests Altria is slightly overvalued at $70.30, our DCF model paints a very different picture, with a future cash flow value of $126.64 and a 44.5% discount to that estimate. Which story do you place more weight on: the cash flows or the narrative multiples?

For a closer look at how this cash flow view is built and what would need to change for the gap to close, Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Altria Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 47 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals on valuation and sentiment, this is a moment to move quickly, review the underlying data for yourself and decide where you stand, and then weigh the company’s potential upsides against the concerns flagged in the 3 key rewards and 3 important warning signs

Looking for more investment ideas?

If you stop at just one stock, you could miss other opportunities that fit your goals even better, so put the Simply Wall Street Screener to work.

• Target dependable cash generators by checking companies in the solid balance sheet and fundamentals stocks screener (47 results) that pair sturdy finances with room for growth.
• Hunt for potential bargains by scanning the 47 high quality undervalued stocks where quality stocks trade at prices that may not fully reflect their fundamentals.
• Dial down volatility risk by focusing on the 63 resilient stocks with low risk scores and find stocks that score well on resilience when markets turn choppy.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.